Targeted genetic sequencing solutions for neurology sector - Medical / Health Care
Over 50 million people globally are impacted by dementia. 25% of those over age 55 have a family history of dementia.*
Tesis Labs Parkinson-Alzheimer-Dementia Panel examines 35 genes associated with an increased risk of developing neurodegenerative conditions: Parkinson’s disease, Alzheimer’s disease, Genetic disorders that cause dementia.
What are the benefits of testing?
Patients identified with a positive test result have an increased risk of developing the associated neurodegenerative disease. Genetic testing may be beneficial in the planning and decision-making process for treatment, psychosocial counseling, research study enrollment, and support programs for caregivers and patients.
The patient’s family members can also be tested to help define their risk. A positive test result for the patient increases the risk for their relatives up to 50%.
Panels that are offered at Tesis Biosciences include:
- Parkinson’s Disease Comprehensive
- Parkinson’s-Alzheimer’s-Dementia
- Autism Disorder
Resource: *(World Alz. Rep ’16)